IP Verse

Hamm&wittkopp patent opposition analysis

The comprehensive analysis of Hamm&wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm&wittkopp

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4034122	Methods For Treating Hyperphenylalaninemia	PTC THERAPEUTICS MP	May 12, 2026	ALFRED E TIEFENBACHER
EP4212152	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Jan 23, 2026	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 23, 2025	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP3270909	Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular Risk	ESPERION THERAPEUTICS	Jul 31, 2024	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP3626270	New Use	NOVARTIS	Jul 10, 2024	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP3110449	Medical Use Of A Dpp-4 Inhibitor	BOEHRINGER INGELHEIM	Mar 26, 2024	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 7, 2023	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP2849754	A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or Sepsis	BOEHRINGER INGELHEIM	Jun 5, 2023	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP2397142	Use Of Dpp Iv Inhibitors	BOEHRINGER INGELHEIM	Apr 19, 2023	ZAKLADY FARMACEUTYCZNE POLPHARMA
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Dec 5, 2022	HEUMANN PHARMA

Top companies who are the clients of Hamm&wittkopp

Company	Total
ZAKLADY FARMACEUTYCZNE POLPHARMA	10
TEVA PHARMACEUTICAL INDUSTRIES	5
HAMM & WITTKOPP	2
ALFRED E TIEFENBACHER	1
SYNTHON BVGENTHON	1
HEUMANN PHARMA	1
BLUEPHARMA INDSTRIA FARMACUTICA	1
GEDEON RICHTER RICHTER HELM BIOLOGICS	1